Conduction system versus biventricular pacing in heart failure with non-left bundle branch block
Eugene S J Tan1,2, Rodney Soh1, Jie-Ying Lee1
1Department of Cardiology, National University Heart Centre, Singapore, Singapore.
Journal of Cardiovascular Electrophysiology
|March 12, 2023
Summary
Conduction system pacing (CSP) is a superior cardiac resynchronization therapy (CRT) for heart failure (HF) patients without left bundle branch block (LBBB). CSP improves cardiac function and survival compared to biventricular pacing (BiV) in this population.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) benefits are reduced in heart failure (HF) patients with non-left bundle branch block (LBBB) conduction delay.
- Biventricular pacing (BiV) is the standard CRT, but its efficacy is limited in non-LBBB HF.
- Conduction system pacing (CSP) offers a potential alternative for CRT in this patient group.
Purpose of the Study:
- To investigate the clinical outcomes of CSP as a CRT strategy in HF patients with non-LBBB conduction delay.
- To compare the efficacy of CSP versus traditional BiV pacing in this specific HF population.
Main Methods:
- A propensity-matched analysis comparing 96 consecutive HF patients with non-LBBB undergoing CSP to BiV recipients.
- Patients were matched for age, sex, HF etiology, and atrial fibrillation (AF).
- Primary outcome: composite of HF hospitalizations or all-cause mortality. Echocardiographic response defined as ≥10% increase in LVEF.
Main Results:
- CSP significantly reduced QRS duration and LV dimensions, unlike BiV.
- Echocardiographic response (LVEF improvement) was more frequent with CSP (51%) than BiV (21%).
- CSP was associated with a 58% reduction in the primary outcome (HF hospitalization or all-cause mortality), driven by reduced all-cause mortality.
Conclusions:
- CSP demonstrates superior electrical synchrony, reverse remodeling, and improved cardiac function compared to BiV in non-LBBB HF patients.
- CSP is associated with significantly better survival outcomes.
- CSP may represent a preferred CRT strategy for heart failure patients with non-LBBB conduction delay.
Related Concept Videos
Conduction System of the Heart
1.3K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
1.3K
Heart Failure Drugs: β-Blockers
411
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
411
Dysrhythmias IV: Characteristics of Bradyarrhythmias
13
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
13
Heart Failure II: Pathophysiology
19
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Heart Failure Drugs: Inotropic Agents
660
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
660
Heart Failure IV: Classification and Diagnostic Evaluation
23
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23


